Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 36
Filtrar
1.
BMC Anesthesiol ; 21(1): 55, 2021 02 16.
Artículo en Inglés | MEDLINE | ID: mdl-33593283

RESUMEN

BACKGROUND: Neuromuscular blocking (NMB) agents are often administered to facilitate tracheal intubation and prevent patient movement during surgical procedures requiring the use of general anesthetics. Incomplete reversal of NMB, can lead to residual NMB, which can increase the risk of post-operative pulmonary complications. Sugammadex is indicated to reverse neuromuscular blockade induced by rocuronium or vecuronium in adults. The aim of this study is to estimate the clinical and economic impact of introducing sugammadex to routine reversal of neuromuscular blockade (NMB) with rocuronium in Spain. METHODS: A decision analytic model was constructed reflecting a set of procedures using rocuronium that resulted in moderate or deep NMB at the end of the procedure. Two scenarios were considered for 537,931 procedures using NMB agents in Spain in 2015: a scenario without sugammadex versus a scenario with sugammadex. Comparators included neostigmine (plus glycopyrrolate) and no reversal agent. The total costs for the healthcare system were estimated from the net of costs of reversal agents and overall cost offsets via reduction in postoperative pneumonias and atelectasis for which incidence rates were based on a Spanish real-world evidence (RWE) study. The model time horizon was assumed to be one year. Costs were expressed in 2019 euros (€) and estimated from the perspective of a healthcare system. One-way sensitivity analysis was carried out by varying each parameter included in the model within a range of +/- 50%. RESULTS: The estimated budget impact of the introduction of sugammadex to the routine reversal of neuromuscular blockade in Spanish hospitals was a net saving of €57.1 million annually. An increase in drug acquisition costs was offset by savings in post-operative pulmonary events, including 4806 post-operative pneumonias and 13,996 cases of atelectasis. The total cost of complications avoided was €70.4 million. All parameters included in the model were tested in sensitivity analysis and were favorable to the scenario with sugammadex. CONCLUSIONS: This economic analysis shows that sugammadex can potentially lead to cost savings for the reversal of rocuronium-induced moderate or profound NMB compared to no reversal and reversal with neostigmine in the Spanish health care setting. The economic model was based on data obtained from Spain and from assumptions from clinical practice and may not be valid for other countries.


Asunto(s)
Bloqueo Neuromuscular/métodos , Fármacos Neuromusculares no Despolarizantes/antagonistas & inhibidores , Seguridad del Paciente/economía , Seguridad del Paciente/estadística & datos numéricos , Sugammadex/economía , Sugammadex/farmacología , Humanos , Bloqueo Neuromuscular/economía , Fármacos Neuromusculares no Despolarizantes/economía , España
2.
Int Nurs Rev ; 56(3): 381-6, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19702814

RESUMEN

AIM: To identify the perception of Primary Health Care (PHC) female nurses in the Balearic Islands in Spain who are smokers, regarding the suitability of their anti-smoking therapeutic relationships with their clients. Also, to identify what factors they consider may determine why nurses smoke less in PHC than in specialized care (SC). BACKGROUND: Backed by the signing of the WHO Framework Convention on Tobacco Control (WHO FCTC), a new Anti-Smoking law has been in force in Spain since 2006. This legislation limits the places where tobacco may be consumed. PHC nurses, because of their professional abilities, their number and their direct contact with society on all accounts - both health- and illness-wise - and also because of the proven efficacy of their interventions in the fight against the smoking habit, are called upon to play an important role against the smoking habit in the 21st century. METHOD: A qualitative study using a semi-structured interview with 15 PHC female nurses who are smokers. FINDINGS: Regarding the therapeutic relationship, basically two attitudes are adopted: first, blaming themselves and feeling uncomfortable and inadequate to be able to help someone to give up smoking or, second, considering themselves to be in an optimum situation in which to be able to help by sharing their addiction and thereby understanding and empathizing much more with clients. PHC nurses believe they smoke less than SC nurses as a result of a greater degree of awareness. CONCLUSION: We would suggest that SC nurses should acquire a more relevant role in the fight against the smoking habit. In light of their capacity, commitment and efficacy, we believe there is a case for total autonomy as far as their role as therapists in breaking smoking habits is concerned.


Asunto(s)
Relaciones Enfermero-Paciente , Enfermeras y Enfermeros/psicología , Atención Primaria de Salud , Fumar/psicología , Adulto , Actitud del Personal de Salud , Femenino , Humanos , Persona de Mediana Edad , Motivación , Rol de la Enfermera , Educación del Paciente como Asunto , Investigación Cualitativa , Cese del Hábito de Fumar/psicología , España
3.
Eur Respir J ; 34(2): 340-5, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19251787

RESUMEN

The endurance time during constant high work-rate exercise (t(LIM)) is used to assess exercise capacity in patients with chronic obstructive pulmonary disease and as an outcome measure for pulmonary rehabilitation. Our study was designed to establish the minimum clinically important difference for the t(LIM). t(LIM) was measured in 105 patients (86 males) before and after an 8-week outpatient pulmonary rehabilitation programme. Subjects were asked to identify, from a five-point Likert scale, the perceived change in their exercise performance immediately upon completion of the exercise tests. The scale ranged from "better" to "worse". The mean+/-sd age was 64+/-5 yrs, forced expiratory volume in 1 s (FEV(1)) 47+/-10% and FEV(1)/forced vital capacity 54.7+/-16.3%. Baseline t(LIM) at 75% of the peak work rate was 397+/-184 s, which increased by 62+/-63% after rehabilitation. In subjects who felt their exercise tolerance was "slightly better", the mean improvement was 34% in the relative improvement over the baseline value (95% CI 29-39)% or 101 (86-116) s compared with 121 (109-134)% in those who reported that their exercise tolerance was "better" and 8 (2-14)% in those who felt their exercise tolerance was "about the same". Minimum clinically important improvement for t(LIM) averaged approximately 33% of baseline. Patients were able to distinguish at least one further additional level of benefit at 120% of baseline.


Asunto(s)
Tolerancia al Ejercicio , Enfermedad Pulmonar Obstructiva Crónica/fisiopatología , Enfermedad Pulmonar Obstructiva Crónica/rehabilitación , Anciano , Ejercicio Físico , Prueba de Esfuerzo , Femenino , Volumen Espiratorio Forzado , Humanos , Masculino , Persona de Mediana Edad , Oximetría , Calidad de Vida , Curva ROC , Reproducibilidad de los Resultados , Capacidad Vital
4.
Int Nurs Rev ; 56(1): 95-101, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19239522

RESUMEN

AIM: To estimate the prevalence of tobacco smoking among physiotherapy and nursing students at the University of the Balearic Islands in Spain and to describe their perceptions, attitude and behaviour towards smoking and towards the Spanish Smoking Prevention Act. BACKGROUND: Active smoking is the first avoidable cause of death in the world while passive smoking is the third. The tobacco epidemic kills 5.4 million people a year from lung cancer, heart disease and other related illnesses. In Europe, around one-third of the Community population are smokers, with about 650,000 smoking-related deaths per year in the Community. In Spain, 56,000 people a year are estimated to die from tobacco-related illnesses. METHOD: An observational, cross-sectional, descriptive study, with a sample of 345 out of 645 students (53.5% participation rate) who completed an anonymous, self-administered, standardized survey devised by the World Health Organization. FINDINGS: The study revealed a 26.1% prevalence of tobacco smoking (26.9% among women and 22.6% among men), which is similar to percentages of students at other Spanish universities. Smokers and non-smokers reported many differences in attitude and behaviour, some of which have potential repercussions in their career, such as in estimating the harmful effects of tobacco smoke or the status of health professionals as role models in the society they serve. CONCLUSION: The results of this study will contribute to develop an anti-smoking programme at the university and to establish smoking-prevention campaigns.


Asunto(s)
Actitud del Personal de Salud , Disonancia Cognitiva , Especialidad de Fisioterapia , Fumar , Estudiantes del Área de la Salud , Estudiantes de Enfermería , Consumo de Bebidas Alcohólicas/epidemiología , Estudios Transversales , Femenino , Hábitos , Conocimientos, Actitudes y Práctica en Salud , Encuestas Epidemiológicas , Humanos , Masculino , Fumar Marihuana/epidemiología , Investigación Metodológica en Enfermería , Especialidad de Fisioterapia/educación , Vigilancia de la Población , Prevalencia , Fumar/epidemiología , Fumar/psicología , España/epidemiología , Estudiantes del Área de la Salud/psicología , Estudiantes del Área de la Salud/estadística & datos numéricos , Estudiantes de Enfermería/psicología , Estudiantes de Enfermería/estadística & datos numéricos , Encuestas y Cuestionarios , Universidades , Adulto Joven
5.
Histol Histopathol ; 22(10): 1091-7, 2007 10.
Artículo en Inglés | MEDLINE | ID: mdl-17616936

RESUMEN

During the period from 2000 to 2003, ninety eight samples of femoral heads were collected. In these pieces, two zones were analyzed: a high-load zone (the hard core of the head) and a low-load zone (the round ligamentum teres zone). As control group, 6 femoral heads (3 of women and 3 of men), proceeding from autopsy in peoples without pathological antecedents and youngs, were studied. After the samples had been embedded in methylmethacrylate and stained, they were subjected to an histomorphometric study. By means of histomorphometry, trabecular bone volume (TBV) and osteoid substance (OSV) was determined. Statistically significant differences were found as for peripheral osteoid volume (low-load zone) (p=0.036) and trabecular bone volume, both peripheral and central. Both volumes decreased in osteoporotic samples and in those from women (p=0.000), in comparison with control group. Regarding the relationship between the high-load and low-load zone, significant data were obtained. The high-load zone had a greater trabecular bone volume than the low-load zone, regardless of the pathology and sex, but this increase was more pronounced in the arthrosic samples and in those from men. Additionally, this trabecular bone volume in the high-load zone decreased with increasing age of the donor (p=0.037), when the control group is compared. In sum, we observed a reduction in the formation of TBV and OSV in osteoporosis but also a decrease in the arthrosic, in samples from older subjects, in women, and in the low-load zone of the samples, when the control group is compared. These data suggest the coexistence of both pathologies, which is more pronounced in older subjects and women.


Asunto(s)
Cabeza Femoral/patología , Osteoartritis de la Cadera/patología , Osteoporosis/patología , Factores de Edad , Anciano , Anciano de 80 o más Años , Femenino , Cabeza Femoral/fisiología , Humanos , Masculino , Persona de Mediana Edad , Osteoartritis de la Cadera/fisiopatología , Osteoporosis/fisiopatología , Soporte de Peso/fisiología
6.
Neurologia ; 22(3): 138-46, 2007 Apr.
Artículo en Español | MEDLINE | ID: mdl-17364251

RESUMEN

INTRODUCTION: The aim of this study was to re-analyze door-to-door studies on neurological diseases among the elderly, in which vascular risk factors (VRF) were studied, describing methodological characteristics and prevalence of VRF. METHODS: The surveys were identified in two phases. They were aimed at ascertaining prevalence of stroke, dementias or Parkinsonisms and, at the time of individual screening, had collected data on at least three of the following VRF: arterial hypertension (AHT), smoking habit, diabetes mellitus and hypercholesterolemia. A questionnaire was drawn up to collect the data reported in each study, and a database was constructed. VRF prevalences were quantified and analyzed using logistic regression. RESULTS: The total of the re-analyzed population was 12,510 persons aged 70 years and over, residents in seven geographic areas during the period 1994-2002. Information available on VRF was essentially self-reported. The prevalence of self-reported AHT was 25.7 % in men and 44.2 % in women, and that of measured AHT was 61 % and 71.9 %, respectively. Populations with arterial pressure obtained by direct measurement registered 138 higher risks (OR: 1.74; 95 % CI: 1.51-2.01, and OR: 1.48; 95% CI: 1.33-1.64). Reported prevalence of diabetes, hypercholesterolemia and smoking habit were 14.3 %, 23.3% and 8.5 %, respectively. CONCLUSIONS: There was a high prevalence of VRF among the Spanish elderly population. However, its relationship with dementia, Parkinsonisms and cerebrovascular disease could not be studied due to the poor quality of the VRF data. The differences between measured and self-reported arterial pressure suggest the existence of undetected AHT and wide scope for prevention.


Asunto(s)
Trastornos Cerebrovasculares/epidemiología , Anciano , Anciano de 80 o más Años , Diabetes Mellitus/epidemiología , Femenino , Encuestas Epidemiológicas , Humanos , Hipercolesterolemia/epidemiología , Hipertensión/epidemiología , Hipertensión/psicología , Masculino , Prevalencia , Proyectos de Investigación , Factores de Riesgo , Fumar/epidemiología , España/epidemiología , Encuestas y Cuestionarios , Enfermedades Vasculares/epidemiología
7.
J Mater Sci Mater Med ; 18(5): 933-41, 2007 May.
Artículo en Inglés | MEDLINE | ID: mdl-17216581

RESUMEN

The biological response to an acrylic bone cement cured with 4,4'-bis-dimethylamino benzydrol (BZN) as activator of reduced cytotoxicity and antiseptic properties, has been carried out and compared with that obtained for CMW 3 cement. Histomorphometrical data (undecalcified trichromic Goldner staining) were obtained by measuring the most significant variables at the bone-cement interface. Quantitative results of tissue response revealed that newly formed bone and connective tissue were maximum at 4 weeks whereas bone marrow increased with time of implantation for both cements. Statistical analysis (p < 0.05) showed no significant differences in newly formed bone and bone marrow with time and between both groups, however, connective tissue significantly decreased between 4 weeks and 12 weeks for BZN cement, and between 12 weeks and 24 weeks for CMW3. By comparing both cements at each time, lower significant percentage of connective tissue at the bone-cement interface of the BZN cement, was obtained at 12 and 24 weeks, however, a very low amount of connective tissue was found for both cements. All the results indicate that the new activated system could be applied clinically in a relatively short time, after the corresponding preclinical study.


Asunto(s)
Antiinfecciosos Locales/química , Antiinfecciosos Locales/farmacología , Cementos para Huesos/química , Cementos para Huesos/farmacología , Animales , Compuestos de Bencidrilo , Médula Ósea/anatomía & histología , Tejido Conectivo/anatomía & histología , Femenino , Fémur/anatomía & histología , Fémur/efectos de los fármacos , Fémur/cirugía , Ensayo de Materiales , Metilmetacrilatos/química , Metilmetacrilatos/farmacología , Polimetil Metacrilato/química , Polimetil Metacrilato/farmacología , Conejos , Factores de Tiempo
8.
Acta Psychiatr Scand Suppl ; (428): 7-10, 36, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16307614

RESUMEN

OBJECTIVE: To evaluate the treatment options in patients who do not respond appropriately to a single antidepressant alone. METHOD: The medical literature was reviewed. RESULTS: A number of strategies are available if a patient fails to respond adequately to initial antidepressant treatment, including the combination with another psychoactive drug. Evidence published to date appears to suggest that benzodiazepines are the drugs most frequently combined with antidepressants. The combination of two antidepressants together is less common, occurring in approximately 5-15% of cases showing a poor initial response. The key figures involved in such co-prescription are psychiatrists. CONCLUSION: There appears to be considerable variability in the data concerning combined prescription of antidepressants, with differences arising depending on the type of physician, the type of patient or illness and the geographical area. It is also unclear how closely research findings parallel with what doctors do in everyday practice.


Asunto(s)
Antidepresivos/uso terapéutico , Trastorno Depresivo/tratamiento farmacológico , Antidepresivos/administración & dosificación , Benzodiazepinas/administración & dosificación , Benzodiazepinas/uso terapéutico , Comparación Transcultural , Trastorno Depresivo/psicología , Esquema de Medicación , Resistencia a Medicamentos , Quimioterapia Combinada , Utilización de Medicamentos , Humanos , Farmacoepidemiología/estadística & datos numéricos , Pautas de la Práctica en Medicina , Psiquiatría/estadística & datos numéricos , Psicotrópicos/administración & dosificación , Psicotrópicos/uso terapéutico , Proyectos de Investigación
9.
Acta Psychiatr Scand Suppl ; (428): 11-3, 36, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16307615

RESUMEN

OBJECTIVE: To review the neuropharmacological basis of antidepressant combination therapy. METHOD: Literature searches and other relevant material were obtained and reviewed. RESULTS: The overall clinical aim of combining antidepressants is to increase the efficacy whilst minimizing the side effects. Although such prescriptions are frequently based on the previous experience and knowledge, a sound neuropharmacological basis to support these combinations is desirable. When combining antidepressants, it is important to combine mechanisms of action, rather than simply one drug with another, and to aim for synergistic effects. The possibilities of combining mechanisms of action should also be exploited to the full if necessary, and the potential exists for combining two independent actions that have synergistic effects on the serotonergic, noradrenergic and even the dopaminergic systems. CONCLUSION: Unfortunately, there are still, as yet, insufficient data to categorically justify choosing one or other combination based only on the neuropharmacological evidence.


Asunto(s)
Antidepresivos/uso terapéutico , Trastorno Depresivo/tratamiento farmacológico , Antidepresivos/administración & dosificación , Antidepresivos/farmacología , Trastorno Depresivo/fisiopatología , Trastorno Depresivo/psicología , Dopamina/fisiología , Sinergismo Farmacológico , Quimioterapia Combinada , Humanos , Neurofarmacología , Norepinefrina/fisiología , Pautas de la Práctica en Medicina , Serotonina/fisiología , Transmisión Sináptica/efectos de los fármacos , Transmisión Sináptica/fisiología
10.
Acta Psychiatr Scand Suppl ; (428): 25-31, 36, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16307617

RESUMEN

OBJECTIVE: To review the current literature on the use of combinations of antidepressive agents. METHOD: Literature searches were undertaken and reviewed on the use of combinations of antidepressants. RESULTS: Data sources included surveys, analyses of prescription records, decision algorithms, clinical reports, and studies comparing the monotherapy with combination therapy. More recent surveys recommend combining different selective serotonin reuptake inhibitors (SSRIs), an SSRI plus bupropion or dual action antidepressants plus an SSRI. Decision algorithms recommend an SSRI plus tricyclic antidepressant (TCA) and more recently bupropion plus venlafaxine or mirtazapine. Few controlled clinical trials comparing the combined therapy with monotherapy have been conducted. Beneficial effects have been reported with combinations of TCAs plus mianserin or SSRIs plus mirtazapine. CONCLUSION: Adding or combining antidepressant medications has advantages for the speed of onset and maintaining the existing response. More rigorous clinical trials comparing combination therapy with monotherapy and for the development of rational treatment guidelines are required.


Asunto(s)
Antidepresivos/uso terapéutico , Trastorno Depresivo/tratamiento farmacológico , Algoritmos , Antidepresivos/administración & dosificación , Ensayos Clínicos como Asunto/estadística & datos numéricos , Recolección de Datos , Trastorno Depresivo/psicología , Quimioterapia Combinada , Utilización de Medicamentos , Humanos , Guías de Práctica Clínica como Asunto , Pautas de la Práctica en Medicina , Psiquiatría/estadística & datos numéricos , Resultado del Tratamiento
11.
Acta Psychiatr Scand Suppl ; (428): 14-24, 36, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16307616

RESUMEN

OBJECTIVE: To review the pharmacological basis of antidepressant potentiation in combination therapy and the clinical evidence for its efficacy. METHOD: Literature searches were undertaken and the results reviewed. RESULTS: Treatment-resistant depression is common (15-30%). Various strategies exist for dealing with resistant depression, including pharmacological potentiation, i.e. adding a treatment that itself does not have antidepressant actions but that enhances the efficacy of the original treatment. Lithium, triiodothyronine (T3) and buspirone are the best studied potentiating drugs, although other options include pindolol, dopaminergic agents, second-generation antipsychotics, psychostimulants, hormones and anticonvulsants. CONCLUSION: Several pharmacological potentiation strategies exist. Whilst good evidence exists for lithium combined with antidepressants, although good results have also been reported with augmentation strategies involving T3 or buspirone.


Asunto(s)
Antidepresivos/uso terapéutico , Trastorno Depresivo/tratamiento farmacológico , Antidepresivos/farmacología , Buspirona/farmacología , Buspirona/uso terapéutico , Trastorno Depresivo/psicología , Resistencia a Medicamentos , Sinergismo Farmacológico , Quimioterapia Combinada , Humanos , Litio/farmacología , Litio/uso terapéutico , Resultado del Tratamiento , Triyodotironina/farmacología , Triyodotironina/uso terapéutico
12.
Acta Psychiatr Scand Suppl ; (428): 32-6, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16307618

RESUMEN

OBJECTIVE: The present study uses the data from a large survey conducted to examine the general practice of Spanish psychiatrists on the use of antidepressant combinations in the treatment of depressive disorders. METHOD: The sample was drawn from specialists and psychiatric residents practicing in Spain who were respondents to a questionnaire distributed during an annual national psychiatry meeting and sent by mail. RESULTS: A total of 1032 questionnaires were collected; following the data-filtering, 831 were analysed. Most psychiatrists (89%) believe that many patients do not respond to the first treatment; in such cases of non-response, 58% choose a combination of antidepressants as the next treatment option. Reasons for using the combined treatments include greater efficacy (57%), overcoming resistance to the first antidepressant (27%), faster onset of action (21%) and avoidance of side effects (17%). The most sought after pharmacological profile was serotonergic-noradrenergic (96%) and the most popular combinations were selective serotonin reuptake inhibitor (SSRI) + mirtazapine, SSRI + reboxetine and SSRI + tricyclic antidepressant. CONCLUSION: Antidepressant combinations are frequently used in clinical practice. Pharmacological profiles are always considered and SSRIs + mirtazapine is the option usually chosen.


Asunto(s)
Antidepresivos/uso terapéutico , Trastorno Depresivo/tratamiento farmacológico , Antidepresivos/administración & dosificación , Recolección de Datos , Trastorno Depresivo/psicología , Quimioterapia Combinada , Utilización de Medicamentos , Humanos , Mianserina/administración & dosificación , Mianserina/análogos & derivados , Mianserina/uso terapéutico , Mirtazapina , Pautas de la Práctica en Medicina , Psiquiatría/estadística & datos numéricos , Inhibidores Selectivos de la Recaptación de Serotonina/administración & dosificación , Inhibidores Selectivos de la Recaptación de Serotonina/uso terapéutico , España , Encuestas y Cuestionarios
13.
Qual Life Res ; 14(2): 463-72, 2005 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15892435

RESUMEN

OBJECTIVE: To assess the impact of PD on informal caregivers of patients and identify the main factors related to caregiver strain. PATIENTS AND METHODS: Pairs of PD patients and their caregivers. Evaluation by neurologists included the Hoehn and Yahr, Schwab and England, UPDRS (parts 1-3), ISAPD, and Pfeiffer's SPMSQ rating scales. Patients completed the Euro-QoL 5D, PDQ-8, and Hospital Anxiety and Depression Scale. The SQLC was used to assess caregivers' quality of life (QoL), with caregivers, in turn, applying the Euro-QoL and PDQ-8 to assess patients' health-related quality of life (HRQoL). Multiple linear regression models were fitted to ascertain factors linked to the SQLC. RESULTS: Significant correlations were in evidence between the following scores: SQLC and clinical rating scales and SQLC and patients' HRQoL. Based on multiple regression analysis, patients' functional state (ADL) proved to be the main predictor of caregivers' QoL. Self- and caregiver-assessed patients' HRQoL also proved to be a relevant factor. CONCLUSIONS: (1) Patients' functional state was significantly related to caregivers' psychosocial burden; (2) patients' HRQoL proved to be an additional factor linked to caregiver QoL; (3) improvement of patient disability and HRQoL might alleviate caregiver strain.


Asunto(s)
Cuidadores/psicología , Enfermedad de Parkinson/enfermería , Calidad de Vida , Anciano , Estudios Transversales , Femenino , Humanos , Masculino , Persona de Mediana Edad , España
14.
Bioelectromagnetics ; 26(1): 20-7, 2005 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15605398

RESUMEN

An experimental study was carried out in rats with the purpose of demonstrating the capacity of pulsed electromagnetic fields (PEMFs) to stimulate regeneration of the peripheral nervous system (PNS). Wistar and Brown Norway (BN) rats were used. Direct sciatic nerve anastomoses were performed after section or allograft interposition. Treatment groups then received 4 weeks of PEMFs. Control groups received no stimulation. The evaluation of the results was carried out by quantitative morphometric analysis, demonstrating a statistically significant increase in regeneration indices (P < 0.05) in the stimulated groups (9000 +/- 5000 and 4000 +/- 6000) compared to the non-stimulated groups (2000 +/- 4000 and 700 +/- 200). An increase of NAD specific isocitrate dehydrogenase (IDH) activity was found along with an increase in the activity of acetyl cholinesterase at the motor plate. The present study might lead to the search for new alternatives in the stimulation of axonal regenerative processes in the PNS and other possible clinical applications.


Asunto(s)
Campos Electromagnéticos , Placa Motora/enzimología , Placa Motora/efectos de la radiación , Regeneración Nerviosa/fisiología , Regeneración Nerviosa/efectos de la radiación , Nervio Ciático/fisiología , Nervio Ciático/efectos de la radiación , Acetilcolinesterasa/metabolismo , Animales , Relación Dosis-Respuesta en la Radiación , Femenino , Isocitrato Deshidrogenasa/metabolismo , Placa Motora/ultraestructura , Traumatismos de los Nervios Periféricos , Nervios Periféricos/citología , Nervios Periféricos/fisiología , Nervios Periféricos/efectos de la radiación , Ratas , Ratas Wistar , Nervio Ciático/citología , Nervio Ciático/lesiones
16.
Biomaterials ; 25(12): 2381-92, 2004 May.
Artículo en Inglés | MEDLINE | ID: mdl-14741603

RESUMEN

Injectable bioactive acrylic formulations based on poly(methyl methacrylate) (PMMA) and different amounts of bioactive glasses in the system SiO2-CaO-Na2O-P2O5 have been prepared in the presence of the anti-inflammatory analgesic drug fosfosal, the sodium salt of 2-phosphonoxibenzoic acid, to be used in minimally invasive surgery. The injectability of the formulations evaluated according to the established protocol was around 80%. The experimental formulations provided maximum temperatures in the range 50-60 degrees C, which were lower than those of commercial acrylic bone cements currently used in percutaneous vertebroplasty (PVP). Residual monomer content of any formulation was inferior to 5%. Compressive yield strength of dry specimens was in the range 80-95 MPa, but it decreased after immersion in SBF to values in the range 30-50 MPa, due to the dissolution of the bioactive glasses and the drug in the medium. The release of fosfosal was evaluated in vitro (pH = 7.0). The release profile against time obtained from a PMMA cement was quasi-linear and the 80% of the initial amount of drug was released in 175 h. However, for bioactive cements, the 80-100% of the fosfosal charged was released in approximately 48 h, due to the dissolution of the glasses in the medium. Values of weight loss of the cements determined gravimetrically ranged between 16% and 26% depending on the initial amount of fosfosal, i.e. 20 or 30 wt%, respectively. The weight loss and the water uptake were simultaneous processes, and values of hydration degree were around 10-14%. The formation of an apatite-like layer was detected on the surface of the cements at different periods of time depending on the composition of the bioactive glasses. The cements containing the glasses with P2O5 produced the growth of the apatite layer in shorter periods of time. The presence of fosfosal accelerated the precipitation of this layer independently on the glasses. The in vivo biocompatibility studied by intramuscular implantation in rats showed the absence of an anti-inflammatory response and a fibrous layer around the implant for the cement prepared with PMMA/fosfosal which is attributed to the therapeutic action of fosfosal acting in situ. The response to cements prepared with bioactive glasses and fosfosal showed a mild inflammatory reaction with the formation of the typical fibrous capsule around the implanted material.


Asunto(s)
Fracturas del Fémur/terapia , Cuerpos Extraños/patología , Vidrio/química , Inyecciones/métodos , Organofosfatos/administración & dosificación , Organofosfatos/química , Polimetil Metacrilato/química , Analgésicos/administración & dosificación , Analgésicos/química , Animales , Antiinflamatorios/administración & dosificación , Antiinflamatorios/química , Materiales Biocompatibles/química , Líquidos Corporales/química , Cerámica , Fuerza Compresiva , Sistemas de Liberación de Medicamentos/métodos , Implantes de Medicamentos/administración & dosificación , Elasticidad , Femenino , Fracturas del Fémur/tratamiento farmacológico , Fracturas del Fémur/patología , Cuerpos Extraños/tratamiento farmacológico , Materiales Manufacturados , Ensayo de Materiales , Músculo Esquelético/efectos de los fármacos , Músculo Esquelético/patología , Conejos , Ratas , Ratas Wistar , Propiedades de Superficie , Resultado del Tratamiento
17.
Arch Bronconeumol ; 40(1): 20-3, 2004 Jan.
Artículo en Español | MEDLINE | ID: mdl-14718117

RESUMEN

OBJECTIVE: During physical exertion, the ventilatory response of patients with severe chronic obstructive pulmonary disease (COPD) is more rapid and shallow than that of healthy subjects. There is evidence that exercise training can alter breathing pattern in COPD patients. The purpose of the present study was to observe the effects of physical training on patients with severe COPD and to determine whether or not any possible changes were maintained over time. MATERIAL AND METHODS: Patients with severe COPD without bronchial reversibility were enrolled in a randomized controlled trial of a peripheral muscle training program carried out in a hospital setting. All enrolled patients were clinically stable, without exacerbation, and were randomly assigned to a training program of high (group A) or low (group B) intensity. RESULTS: Thirty-five men with severe COPD in stable condition (mean [SD] forced expiratory volume in 1 second at 41%[7%]) were enrolled in the study. The mean age was 64(5) years. Group A underwent training at 70(22) W and group B at 35(10) W, such that the estimated total work was 8050(2882) kJ in group A and 4044(1205) kJ in group B. Breathing pattern changes were detected in exercise tests only for group A patients, but the changes were not maintained 12 months after the end of the program. CONCLUSIONS: Intense training produces changes in the breathing pattern of patients with severe COPD. The changes are not specific to the task performed, not dependent on lactate production, and not maintained over the long term.


Asunto(s)
Ejercicios Respiratorios , Terapia por Ejercicio/métodos , Enfermedad Pulmonar Obstructiva Crónica/rehabilitación , Músculos Respiratorios/fisiopatología , Anciano , Humanos , Masculino , Persona de Mediana Edad , Educación y Entrenamiento Físico , Resistencia Física , Enfermedad Pulmonar Obstructiva Crónica/fisiopatología , Respiración , Pruebas de Función Respiratoria , Resultado del Tratamiento
18.
Arch. bronconeumol. (Ed. impr.) ; 40(1): 20-23, ene. 2004.
Artículo en Es | IBECS | ID: ibc-28498

RESUMEN

OBJETIVO: Durante el esfuerzo físico la respuesta ventilatoria de los enfermos con enfermedad pulmonar obstructiva crónica (EPOC) grave es más rápida y superficial que la de los sujetos sanos, y existen indicios de que el entrenamiento físico podría cambiar el patrón ventilatorio de estos pacientes. El propósito del presente estudio fue comprobar los efectos que el entrenamiento físico de los pacientes con EPOC grave tiene sobre el patrón ventilatorio, así como determinar o no el mantenimiento de los posibles cambios producidos en el tiempo. MATERIAL Y MÉTODO: Se realizó un estudio aleatorio y controlado con pacientes con EPOC grave sin reversibilidad bronquial. En estos pacientes se efectuó una intervención mediante entrenamiento físico. Los pacientes fueron remitidos al hospital para entrenamiento muscular periférico, todos ellos en situación clínica estable, sin exacerbación, y fueron asignados a dos programas diferentes de entrenamiento físico. RESULTADOS: Se estudiaron 35 pacientes varones con EPOC grave, estables (volumen espiratorio forzado en el primer segundo del 41 ñ 7 por ciento), con una edad media de 64 ñ 5 años, divididos en dos grupos con diferente potencia media estimada de entrenamiento (grupo A: 70 ñ 22 W; grupo B: 35 ñ 10 W) y trabajo total desarrollado (grupo A: 8.050 ñ 2.882 kJ; grupo B: 4.044 ñ 1.205 kJ). Sólo se objetivaron cambios en el patrón ventilatorio durante el ejercicio realizado durante la prueba de esfuerzo en el grupo A, que no se mantuvieron a los 12 meses de finalizado el programa. CONCLUSIONES: El entrenamiento intenso produce cambios en el patrón ventilatorio de los pacientes con EPOC grave que son inespecíficos de la tarea e independientes de la producción de lactato, y que no se mantienen a largo plazo (AU)


Asunto(s)
Persona de Mediana Edad , Anciano , Masculino , Humanos , Ejercicios Respiratorios , Resultado del Tratamiento , Educación y Entrenamiento Físico , Resistencia Física , Músculos Respiratorios , Respiración , Enfermedad Pulmonar Obstructiva Crónica , Terapia por Ejercicio , Pruebas de Función Respiratoria
19.
J Biomed Mater Res B Appl Biomater ; 66(2): 502-13, 2003 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-12861600

RESUMEN

Acrylic bone cements prepared with activators of reduced toxicity have been formulated with the aim of improving the biocompatibility of the final material. The activators used were N,N-dimethylaminobenzyl alcohol (DMOH) and 4,4'-dimethylamino benzydrol (BZN). The toxicity, cytotoxicity, and antiseptic action of these activators were first studied. DMOH and BZN presented LD50 values 3-4 times higher than DMT, were less cytotoxic against polymorphonuclear leucocytes, and possessed an antimicrobial character, with a high activity against the most representative microorganisms involved in postoperative infections. The properties of the acrylic bone cements formulated with DMOH and BZN were evaluated to determine the influence of these activators on the curing process and the physicochemical characteristics of the cements. A decrease of the peak temperature was observed for the curing with DMOH or BZN with respect to that of one commercially available formulation (CMW 3). However, residual monomer content and mechanical properties in tension and compression were comparable to those of CMW 3. The biocompatibility of acrylic bone cements containing DMOH or BZN was studied and compared with CMW 3. To that end, intramuscular and intraosseous implantation procedures were carried out and the results were obtained from the histological analysis of the surrounding tissues at different periods of time. Implantation of rods of cement into the dorsal muscle of rats showed the presence of a membrane of connective tissue, which increased in collagen fibers with time of implantation, for all formulations. The intraosseous implantation of the cements in the dough state in the femur of rabbits, revealed a higher and early osseous neoformation, with the presence of osteoid material surrounding the rest of the cured material, for the cement prepared with the activator BZN in comparison with that obtained following the implantation of the cement cured with DMOH or DMT (CMW 3).


Asunto(s)
Alcoholes/toxicidad , Aminas/toxicidad , Antiinfecciosos Locales/toxicidad , Materiales Biocompatibles/metabolismo , Polimetil Metacrilato/metabolismo , Alcoholes/química , Alcoholes/metabolismo , Aminas/química , Aminas/metabolismo , Animales , Antiinfecciosos Locales/química , Antiinfecciosos Locales/metabolismo , Huesos/citología , Huesos/metabolismo , Femenino , Masculino , Ensayo de Materiales , Ratones , Neutrófilos/efectos de los fármacos , Neutrófilos/metabolismo , Prótesis e Implantes , Conejos , Ratas , Ratas Wistar
20.
Arch Orthop Trauma Surg ; 123(2-3): 115-7, 2003 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12721691

RESUMEN

A case of periosteal ganglion in a 10-year-old boy is reported. The diagnosis of periosteal ganglion was made on roentgenographic and MR appearance and histologic evidence. The patient was successfully treated by excision. The follow-up examination showed no recurrence. Periosteal ganglia must be considered a cause of expanding cortical erosions. This lesion may mimic other peripheral expanding lesions.


Asunto(s)
Quistes Óseos/cirugía , Periostio , Quistes Óseos/diagnóstico , Niño , Humanos , Imagen por Resonancia Magnética , Masculino , Periostio/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA